利弗莫尔证券显示，派格生物医药-B香港上市首日跌幅扩大至20%。
Group 1 - Livermore Securities reported that the first-day decline of Peijia Medical-B in Hong Kong has expanded to 20% [1]
Group 1 - Livermore Securities reported that the first-day decline of Peijia Medical-B in Hong Kong has expanded to 20% [1]